Axis Capital Holdings Q4 EPS $2.13 Up From $(0.20) YoY

Axis Capital Holdings (NYSE:AXS) reported quarterly earnings of $2.13 per share. This is a 1165 percent increase over losses of $(0.20) per share from the same period last year.

byBenzinga Newsdesk

January 26, 2022

1 minute read

Axis Capital Holdings (NYSE:AXS) reported quarterly earnings of $2.13 per share. This is a 1165 percent increase over losses of $(0.20) per share from the same period last year.

Why Bellicum Pharmaceuticals Stock Is Plunging Today

By Vandana Singh

Today, 5:11 PM

Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) announced the presentation of early Phase 1 results for BPX-601 at the American Society of Clinical Oncology…

BLCM

PNM Reports Filed Notice Of Appeal In Mexico Related To Decision To Deny Application For Abandon, Sale, Securitization Of Minority Interest In Four Corners Power Plant

By Benzinga Newsdesk

Today, 5:11 PM

Today, PNM filed a Notice of Appeal with the New Mexico Supreme Court of the decision earlier this month by the New Mexico Public Regulation Commission (NMPRC) to deny the application by Public Service Company of New

PNM

TFF Pharmaceuticals Shares Spike Higher; Co, Augmenta Bioworks Publish In Vivo Data Co Says Shows Dry Powder Formulation Of COVID-19 Antibody, AUG-3387, Neutralizes SARS-CoV-2 Infection And Reduces Viral Load

By Benzinga Newsdesk

Today, 5:11 PM

TFF Pharmaceuticals, Inc. (NASDAQ:TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology

TFFP

Mizuho Maintains Neutral on Continental Resources, Raises Price Target to $72

By Benzinga Newsdesk

Today, 5:11 PM

Mizuho analyst Vincent Lovaglio maintains Continental Resources (NYSE:CLR) with a Neutral and raises the price target from $59 to $72.

CLR

Axis Capital Holdings Q4 EPS $2.13 Up From $(0.20) YoY

Related Posts

Why Bellicum Pharmaceuticals Stock Is Plunging Today

PNM Reports Filed Notice Of Appeal In Mexico Related To Decision To Deny Application For Abandon, Sale, Securitization Of Minority Interest In Four Corners Power Plant

TFF Pharmaceuticals Shares Spike Higher; Co, Augmenta Bioworks Publish In Vivo Data Co Says Shows Dry Powder Formulation Of COVID-19 Antibody, AUG-3387, Neutralizes SARS-CoV-2 Infection And Reduces Viral Load

Mizuho Maintains Neutral on Continental Resources, Raises Price Target to $72